Floatz logo

Duloxetine

Postpartum Depression

Yale UniversitySmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Postpartum Depression cohort.

Asset / SponsorPhaseRating
ALLOPREGNAN-3.ALPHA.-OL-20-ONE
Supernus Pharmaceuticals, Inc.
Phase 3BBB
Sertraline
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase 4BB
Zuranolone
Biogen
Phase 3BB
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)-
Stanford University
Phase 4BB
Cipralex
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase 3BB

View all 12 →

Same molecule, other indications

Duloxetine is also rated in:

Diabetic NeuropathiesDormant
A
Indicative ·
83 / 100
View asset →
diabetic neuropathyDormant
A
Indicative ·
81 / 100
View asset →
diabetic neuropathyDormant
BBB
Indicative ·
79 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →